- Clinical Trials
- April 2025
- 60 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP
- Report
- February 2025
- 222 Pages
Global
From €2237EUR$2,500USD£1,966GBP
- Report
- June 2024
- 200 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Report
- May 2024
- 137 Pages
Global
From €4942EUR$5,524USD£4,345GBP
€5814EUR$6,499USD£5,112GBP
The Skin Disease Drugs market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin diseases and conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Common treatments include topical creams, ointments, and oral medications. Many of these drugs are available over-the-counter, while others require a prescription from a doctor.
The Skin Disease Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson, and Merck. Other companies include Allergan, Sanofi, Bayer, and Mylan. Show Less Read more